Isolde Summerer

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Trisomy 8 in myeloid neoplasms: more than a passenger alteration?

Trisomy 8 in myeloid neoplasms: more than a passenger alteration?

Journal: Haematologica
Published: August 04, 2026

Subclonal MECOM rearrangements in myeloid neoplasms: enriched for TP53 mutations and adverse outcome.

Subclonal MECOM rearrangements in myeloid neoplasms: enriched for TP53 mutations and adverse outcome.

Journal: Leukemia
Published: May 28, 2026

Genetic characterization of AML defined by differentiation shows a high frequency of DDX41 mutations.

Genetic characterization of AML defined by differentiation shows a high frequency of DDX41 mutations.

Journal: British journal of haematology
Published: February 04, 2026

The clinical relevance of sole loss of chromosome Y in myeloid neoplasms.

The clinical relevance of sole loss of chromosome Y in myeloid neoplasms.

Journal: Blood cancer journal
Published: February 03, 2026

Complex Karyotype in CLL-How to Count Cytogenetic Aberrations Consistently and Efficiently.

Complex Karyotype in CLL-How to Count Cytogenetic Aberrations Consistently and Efficiently.

Journal: Genes, chromosomes & cancer
Published: January 28, 2026

IDH1- and IDH2-mutated myeloid neoplasms: mutational pattern, clonal hierarchy, and the role in AML transformation.

IDH1- and IDH2-mutated myeloid neoplasms: mutational pattern, clonal hierarchy, and the role in AML transformation.

Journal: Blood advances
Published: December 12, 2025

SRSF2 mutations in CCUS, MDS and AML: a cross-entity study.

SRSF2 mutations in CCUS, MDS and AML: a cross-entity study.

Journal: Blood neoplasia
Published: April 14, 2025

Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity.

Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity.

Journal: Blood cancer journal
Published: December 05, 2024

Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients.

Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients.

Journal: Leukemia
Published: March 21, 2024

Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.

Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.

Journal: Leukemia
Published: October 06, 2022

Comprehensive analysis of the genetic landscape of 21 cases with blastic plasmacytoid dendritic cell neoplasm by whole genome and whole transcriptome sequencing.

Comprehensive analysis of the genetic landscape of 21 cases with blastic plasmacytoid dendritic cell neoplasm by whole genome and whole transcriptome sequencing.

Journal: Leukemia & lymphoma
Published: May 26, 2021

Prognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count.

Prognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count.

Journal: Leukemia & lymphoma
Published: March 20, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026